Share Facebook Twitter LinkedIn Pinterest Email Kymera Therapeutics GAAP EPS of -$0.88 misses by $0.11, revenue of $7.4M misses by $7.41M
Walmart raises FY2027 EPS outlook to $2.80-$2.87 while projecting Q3 sales growth of 3%-3.75% (NASDAQ:WMT)August 20, 2026
By Press Room
By Press Room
By Press Room
